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Depression is estimated to affect 350 million people worldwide and is the leading 
cause of disability (WHO, 2012).  According to the Center for Disease Control (CDC) 8% 
of the U.S. population age 12 years or older report current depressive symptoms, while 
approximately 8 million ambulatory care visits result in the diagnosis of major depressive 
disorder per year (Centers for Disease Control, 2011; Centers for Disease Control, 2012).  
Twice annually, college students are asked to complete a college health assessment by The 
American College Health Association (ACHA).  Each year this health assessment provides 
a startling look at the mental health status of American college students.  In the spring of 
2013, ACHA released the results showing 45% (n= 55,385) of college students stated they 
“felt things were hopeless”, 31.3% (n=38,523) “felt so depressed it was difficult to 
function”, while 7.4% (n=9,107) had seriously considered suicide, and 1.5% (n=1,846) had 
attempted suicide in the preceding 12 months.   
Screening for depression in primary care has been supported by the World Health 
Organization, the U.S. Preventive Services Task Force, and the American Academy of 
Family Physicians (AAFP).  The AAFP and U.S. Preventive Services Task Force both 
recommend clinics with the capability to treat depression should screen adults 18 years and 
older at every visit.  The Institute for Clinical Systems Improvement developed a guideline 
titled Adult Depression in Primary Care (Mitchell et al., 2013) to assist providers in the 
assessment, diagnosis, and treatment of depression. 
Despite these statistics and guidelines, many providers struggle to implement 
depression screening.  The purpose of this practice inquiry project was to evaluate potential 
changes in provider’s documentation of depression screening after implementing a provider 
education session and the use of a depression screening tool.  This practice inquiry project 
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consists of three manuscripts each of which provide further insight for the implementation 
of a depression screening program. 
 Manuscript one is an integrative review of literature that assisted in providing the 
foundation for this project.  The integrative review focused on reported barriers to 
the implementation of depression screening programs, depression screening tools, 
and published reports of successful integration of depression screening. 
 Manuscript two is a review of the guideline Adult Depression in Primary Care 
(Mitchell et al., 2013).  This guideline provided guidance in the creation of the 
depression screening program implemented in this practice inquiry project. 
 Manuscript three describes the development, implementation, and evaluation of a 
depression screening program at a large university student health clinic. 
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Manuscript 1 
 
Implementation of Depression Screening in the Primary Care Setting: 
An Integrative Review 
Mary Kate Stafford 
University of Kentucky 
College of Nursing 
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Implementation of Depression Screening in the Primary Care setting: An Integrative 
Review 
According to the Center for Disease Control, approximately 25 million 
Americans, age 12 years or older report current depression (2012), and in 2009-2010 
eight million ambulatory care visits resulted in the primary diagnosis of major depressive 
disorder (2013).  With the vast number of patients experiencing depression and 
depressive symptoms, depression screening rates are astoundingly low with only 2.2% of 
primary care office visits having depression screening documented as performed.  In an 
attempt to improve these rates, Healthy People 2020 objective MDMD 11.1 calls for an 
increase in the percentage of primary care providers who screen patients for depression 
during office visits from 2.2% to 2.4% (2012).   
 Depressive symptoms have the ability to interfere with all aspects of a person’s 
life including interpersonal relationships, physical health, and having a functioning role 
in society.  As a society, the burden of depression is experienced through the cost of 
someone’s life, decreased work productivity, and increased cost of medical care (U.S. 
Preventive Services Task Force, 2009). The recommendation for depression screening in 
primary care has been supported by the World Health Organization (WHO), the U.S. 
Preventive Services Task Force (USPSTF), and the American Academy of Family 
Physicians (AAFP) (WHO, 2013; USPSTF, 2015; & AAFP, 2012).  AAFP’s guideline, 
Screening for Depression, recommends providers screen for depression in adult 
populations when staff-assisted depression care supports are in place (2012).  The 
AAFP’s guideline for depression screening coincides with the recommendation of the 
U.S. Preventive Task Force that adults should be screened for depression in practices that 
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have the ability to correctly diagnose, effectively treat, and provide follow-up care 
(2002).   
Despite these recommendations, many providers struggle to implement 
depression screening due to the multitude of factors that serve as barriers to depression 
screening.  Barriers to depression screening include limited appointment time to screen 
and address other chief complaints, lower priority during the appointment, limited 
resources within office to screen, limited community resources to treat and follow-up on 
positive screens, and potential limited knowledge regarding screening recommendations 
and screening tools.  Therefore, the focus of this literature review is to understand 
potential barriers to and suggestions for the implementation of a successful depression 
screening program.  
Methods 
Before implementing a screening program, it is imperative to review the literature 
for other programs that have been both successful and found areas for growth.  This 
author attempted to find programs that addressed and attempted to overcome common 
barriers to depression screening.  Previous research has shown barriers to depression 
screening to include the following: lack of knowledge regarding current guidelines, lack 
of providers’ confidence in screening and treating depression, lack of resources to 
diagnosis, treat, and manage depression, and the providers’ limited time with a patient 
(Machado & Tomlinson, 2011).   
To assist with the literature search, the following PICOT question was 
formulated: In primary care patients 18 years or older, what are the barriers to depression 
screening?  A search of the literature was conducted using CINAHL, Cochrane Library, 
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PubMed, and MedLine.  The following terms were used while performing the search: 
depression, screening, program, project, primary care, implementation, nurse practitioner, 
and family physician.  Based on the search terms, the original search yielded 225 articles.  
Using inclusion and exclusion criteria, seven articles were selected to be included in this 
review.  The inclusion criteria for this review included: English language, peer-reviewed 
journal, participants 18 years or older, depression screening, and the primary care setting.  
Studies that were excluded included those containing a non-English language, patient 
populations with co-morbid conditions, depression interventions other than screening, 
patient populations with children and adolescents, and settings other than primary care 
were excluded from this review.   
To analyze the literature, the strength of recommendation taxonomy (SORT) 
method was utilized to provide the literature grades from levels one to three (Ebell et al., 
2004).  Within the SORT method (see Table 1), level one is assigned to good-quality, 
patient-centered evidence presented through randomized-control trials.  A level two 
distinction is given to limited-quality patient-centered evidence and includes systematic 
reviews and meta-analyses.  Lastly, a level three distinction is given to other evidence 
presented through guidelines, general practice, expert opinion, or case studies (Ebell et 
al., 2004). 
Findings 
 The initial literature search returned many studies related to depression, however 
only two provided synthesis of current evidence to support or negate the use of routine 
depression screening, while the remaining five articles addressed barriers related to 
depression screening.  A systematic review (level I in SORT methodology) conducted by 
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Gilbody, House, and Sheldon (2009) was performed reviewing 12 studies with the 
purpose of evaluating the effectiveness of depression screening in improving the 
recognition and management of depression.  Of the 12 studies, nine were performed in 
the primary care setting, two in a general outpatient setting, and one in an elderly 
inpatient setting.  The patients within these nine studies fell within two populations: 1) 
patients were included regardless of their baseline screening score or probability of 
having depression and 2) a high-risk population where patients were only included and 
randomized if they scored above certain scores on the depression screening tool.  The 
intervention groups consisted of reporting the depression screening scores to the 
providers versus the control groups where depression screening scores were not reported 
to the healthcare provider. 
 Nine of the studies included in this systematic review addressed the potential 
effects of screening on the recognition of depression (Gilbody, House, & Sheldon, 2009).  
Overall, the studies showed a very slight positive increase on depression recognition with 
the use of a depression screening tool with a relative risk of 1.38 (95 % confidence 
interval 1.78 to 3.96).  A more significantly positive increase was shown in three studies 
that only used high risk populations with patients scoring higher on the depression 
screening tools (relative risk 2.66, 95% confidence interval 1.78-3.96).  This effect was 
lessened by the six studies that utilized the unselected feedback patient populations, 
which provided no improvement in the recognition of depression recognition (relative 
risk 1.00, 95% confidence interval 0.89-1.13). 
 Gilbody, House, & Sheldon (2009) also reviewed the effects of screening on the 
management of depression, with eight of the 12 studies addressing this objective.  The 
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authors included any documented intervention as a positive outcome for the management 
of depression.  Although overall the studies provided a slightly higher intervention rate 
(relative risk 1.35, 95% confidence interval 0.98 to 1.85) in the studies utilizing a 
depression screening tool, these results were primarily due to two studies using the high 
risk patient populations versus the patient populations including all patients screened 
regardless of risk.  Lastly, using four of the 12 studies the authors addressed the potential 
effects of depression screening on long-term outcomes of depression finding no 
significant improvement at zero to six months or at a 12 month follow-up. 
 In comparison to the above systematic review, O’Connor, Whitlock, Gaynes, and 
Beil (2009) conducted a systematic review (level I evidence) with the primary objective 
of reviewing updated evidence regarding the Agency for Health Care Research and 
Quality’s B grading supporting depression screening in primary care.  This systematic 
review served as an update of literature following the 2002 systematic review conducted 
by Pignone, et al., which served as the original foundation supporting the 
recommendation.  The authors asked key questions to guide their research specifically 
focusing on if screening for depression would reduce morbidity and mortality, and if any 
potential harms related to depression screening had been documented.  To evaluate 
reduction of morbidity and mortality, only one study was found that specifically 
attempted to compare a screened versus unscreened group.  Within the screened group, 
969 patients were randomly assigned and were screened prior to their appointment with 
the provider, a non-screening group was also utilized in which the patients were not 
screened prior to their appointment but were screened after to evaluate for depressive 
symptoms.  The authors found the depressed patients screened for depression were more 
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likely to have recovered at 3 months (with less than 1 depressive symptom) compared to 
the unscreened group.  However, when combining the groups, the study lacked the 
necessary power to apply their results to a broader population.   
O’Connor, Whitlock, Gaynes, and Beil (2009) also attempted to address the 
potential impact of provider response to screening results on the recovery from 
depression by reviewing eight randomized control trials with varying screening and 
levels of intervention strategies to address positive depression screens.  Within the eight 
studies, conflicting reports of potential reduction of depressive symptoms were given, 
with the more significant impact reported in studies with greater availability of resources 
for intervention.  The authors deduced a potential decrease in depressive symptoms with 
intervention resources available, yet the authors were unable to specifically identify the 
effect of provider feedback related to depression screening scores.  Regardless of the 
mixed review, O’Connor, Whitlock, Gaynes, and Beil (2009) did not find reports of 
potential harm in screening patients for depression, and the U.S. Preventive Services 
Task Force used this review as part of the evidence to support depression screening in 
primary care. 
The remaining articles retrieved in the literature search addressed the multitude of 
barriers to screening for depression in primary care that have been cited in the literature.  
Although the major guidelines recommended screening, this recommendation is based on 
the foundation that supports are in place to provide adequate diagnosis, treatment, and 
follow-up for patients.  One barrier that was hypothesized was lack of provider 
knowledge regarding current guidelines.  As demonstrated by the two systematic reviews, 
conflicting data exists regarding support for depression screening.  In an attempt to 
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disseminate the recommendations from USPSTF, Richardson and Puskar (2012) provided 
a brief overview of the recommendation to screen only when staff-supported resources 
are in place (evidence level II).  The authors reviewed seven potential screening tools 
providers might utilize, with the majority of their focus on the PHQ-9, including its 81% 
sensitivity and 92% specificity.  As supported by USPSTF, the authors stressed the 
importance of follow-up care with the patient. 
To provide further confidence in screening recommendations, Roman and Callen 
(2008) provided brief summaries of eight screening tools available for adults in primary 
care.  The authors sought to find instruments that were brief (to save the provider time 
and keep from tiring an older adult patient) and were evidence-based.  In harmony with 
the USPTF recommendations, Roman and Callen (2008) stressed the need for a delivery 
system to care for patients needing further evaluation and treatment of depression.  
However, this summary of the literature functioned as a quick overview and would allow 
a provider to quickly decide which tool may fit specific situations.  Although this study 
provided a review of the literature, it would be given the evidence rating of Level Three. 
Staff-supported resources may include trained staff to provide screening, access to 
screening tools, patient education materials, and the ability to follow-up and treat whether 
it is the primary care provider or a mental health provider within the community.  
Cashman, Hale, Candib, Nimiroski, and Brookings (2006) attempted to address the 
barriers related to staffing resources as they studied the implementation of a pilot 
depression screening program.  Stating the USPTF’s recommendation for screening of 
depression and a previously performed internal audit showing 33% of patients having a 
diagnosis of depression, Cashman et al. (2006) developed a screening program.   
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In the formative stages of this program, medical assistants and nurses were trained 
to recognize the difference between depression and grief, as well as the use of the Center 
for Epidemiologic Studies-Depression Screen (CES-D) (Cashman et al., 2006).  
However, due to limited staff resources, the authors trialed the use of first-year graduate 
nursing students (GSNs) to provide consistent depression screening.  Providers picked 
red-flag patients for which the GSNs provided the depression screening instead of 
providing depression screening to all patients.  In eight months of screening, 117 patients 
(out of 207) responded positively to one of the two screening questions of the CES-D, 
while 100 patients were diagnosed with depression.  Of these 100 patients, 84% accepted 
a form of treatment (cognitive therapy, pharmacologic, or watch and wait).   
 Although Cashman et al (2006) found the use of GSNs beneficial in providing 
additional providers to screen patients, the use of students was not a reliable avenue for 
fulfilling staffing shortages.  The authors found other barriers in implementing their pilot 
program which included: limited lime for screening, limited time for investigating other 
risk factors, the need for interpreters, and issues with the information technology used.  
Using the strength of recommendation taxonomy (see Table 1), Cashman et al. (2006) 
study would be considered a Level Two, as this study is a non-randomized control trial. 
 Multiple authors have attempted to address the barrier of time necessary to 
perform depression screening.  Schmitt, Miller, Harrison, Touchet (2010) attempted to 
address the barrier of time in regards to depression screening.  The authors utilized data 
from the National Ambulatory Medical Care Survey which included data regarding 
patient visits within 17,463 physician offices.  Of the patient visits 3.4% documented 
depression screening and was associated with increased probability of having longer visit 
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duration when compared to visits without depression screening.  The authors explained 
due to the increase in appointment time a lack of incentive exists for depression screening 
for primary care providers.  The lack of incentives include increased visit duration of 1 to 
15 additional minutes (with the mean of 6 minutes added to the appointment), increased 
cost due to staff and resources, and limited reimbursement.  As seen in Table 2, this 
qualitative study has an evidence level rating of two. 
In a desire to meet current recommendations regarding screening and attempting 
to be mindful of time, Farrell et al. (2009a) sought to decrease the amount of  time 
necessary for depression screening through the use of touch screen computer-based 
technology.  The authors performed initial depression screening in a rural, primary care 
setting using the PHQ-9 questionnaire.  The setting for this study was the University 
Medical Associates (UMA) at the University of Virginia Primary Care Clinic.  The 
investigators first piloted a small study (9 participants) to critique the use of a touch 
screen computer to facilitate depression screening.  The authors found the participants 
and medical providers were accepting of the electronic program, as long as it worked into 
the flow of the clinic visit and was in a convenient location within the office. 
 The implementation of the screening program has been described in a second 
article by Farrell et al. (2009b).  After piloting the use of computer touch screens with 
nine participants and receiving feedback, the authors attempted to implement the 
screening program with a small convenience sample of 20 participants with the average 
age of 44.  Of these participants, 20% were found to have depression needing treatment, 
while 25% needed further evaluation.  The authors also reported the average time 
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required for a patient to complete the electronic depression screening to have been less 
than three minutes. 
Gap Analysis 
 Thus far, the evidence has provided conflicting, minimal support for the 
recommendations regarding depression screening.  The two systematic reviews showed 
only minimal decreases in mortality or morbidity, as well as minimal improvement in 
overall depressive symptoms when comparing entire study samples.  One downfall to the 
studies discussed in both systematic reviews, is the potential for confounding variables 
and the difficulty to truly extract positive impacts depression screening alone has on 
overall mortality and morbidity.  However, regardless of the minimal improvement, no 
adverse effects of depression screening have been identified therefore allowing the 
recommendations to continue to stand.  
 The literature does support the use of screening tools with a variety being tested 
and validated in the primary care setting and the literature provides several consolidated 
reviews (Richardson & Puskar, 2012; Roman & Callen, 2008).  With the variety of 
screening tools, the provider may be able to choose an appropriate tool for differing 
situations for goodness of fit (Roman & Callen, 2008).  It is beyond the scope of this 
paper to individually review each screening tool and the tool’s potential in differing 
settings.   
 It has been shown depression screening does increase the duration of office visits, 
(Schmitt, Miller, Harrison, & Touchet, 2010).  To overcome this particular barrier, 
studies have been performed to look at the use of different technologies for screening, 
such as the example of the use of computer-based screening tools in patients (Farrell et 
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al., 2009).  Further analysis of the literature could be performed specifically comparing 
various screening methods such as the use of paper encounter forms, electronic sign-in, 
and provider administered screening.  Regardless of the tool used for depressions 
screening, Cashman, et al. (2004) found an increased incidence of positive identifiers for 
depression, therefore allowing for increased diagnostic screening, and treatment or 
referral. 
 The literature provided by the systematic reviews focused on an all-encompassing 
inclusion criteria of adults (18 years or older), with several focusing on specifically the 
older adult.  During the literature the author found little information on specifically the 
young adult population ranging from 18 to 35 years old.  Further research could be 
conducted on this age group due to the many changes and new stressors this population 
faces.  These changes and stressors include college, beginning careers and families, 
becoming independent from their parents, and changes in support groups. 
 Schmitt et al. (2010) suggest further research should be performed to analyze the 
real-world application of depression screening.  Few figures have been published 
regarding the cost versus benefit of implementing a depression screening program in the 
primary care setting.  As mentioned above, Schmitt et al. (2010) also notes increased cost 
and decreased reimbursement as a barrier. 
 Lastly, one limitation cited by both Gilbody, House, and Sheldon (2009) and 
O’Connor, Whitlock, Gaynes, and Beil (2009) is that most studies regarding 
implementation of depression screening programs have been small pilot studies, which 
make the results more difficult to generalize to an entire population.  With the current 
guideline stating the need for screening of all patients but only in a system that has the 
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support for referral, treatment, and follow-up; more effort needs to be applied in creating 
and analyzing macrosystem changes related to depression screening. 
 Overall, the literature is lacking in its strength of evidence as discussed by 
Gilbody, House, and Sheldon (2009) and O’Connor, Whitlock, Gaynes, and Beil (2009).  
With several different depression screening tools, a variety of populations and settings, 
and many ideas on how to implement, there is little consistency within the evidence.  
Also lacking within the literature are descriptions of successful program implementation 
larger than a small pilot study.  Finally, the evidence providing cost analysis is minimal, 
creating larger barrier to implementing depression screening programs. 
Recommendations 
 Although the literature review focused on the many barriers to implementing a 
depression screening program, the studies all recommended specific designs for the 
implementation of a depression screening program.  Richardson and Puskar (2012) and 
Roman & Callen (2008) strived to educate providers regarding the current validated 
depression screening tools available, including the general adult population and the older 
adult population.  Schmitt et al. (2010) recommended the use of the PHQ-9 screening tool 
due to its specificity and sensitivity as well as its brevity.  Cashman et al. (2004), 
recommended the use of screening questions in the patient encounter form.  The use of 
the encounter form while the patient was waiting to be seen was thought to decrease the 
time required for staff to screen and review the depression screening tool.  Schmitt et al. 
(2010) utilized computers to screen patients for depression, similar to the study of Farrell 
et al. (2009). 
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 The implementation of a depression screening program is multifaceted and 
requires the knowledge and research of many.  Further studies are needed regarding 
specific implementation strategies, those that are both successful and not as successful.  
Lastly, cost analysis should be provided in future implementation programs.  Cost 
analyses would allow for future program planners to evaluate strategies to increase 
incentives for primary care providers to perform depression screening for all adult 
patients. 
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Table 1. Grading Criteria Legend – SORT Method 
Study Quality Diagnosis Treatment/prevention/screening Prognosis 
Level 1: 
Good 
Quality, 
patient-
oriented 
evidence 
Validated 
clinical decision 
rule SR/meta-
analysis of high-
quality studies.  
High-quality 
diagnostic 
study. 
SR/meta-analysis or RCTs with 
consistent findings. 
High quality individual RCT. 
All-or-none Study 
SR/meta-analysis 
of good quality 
cohort studies. 
Prospective 
cohort study with 
good follow-up. 
 
Level 2: 
limited-
quality 
patient-
oriented 
evidence 
Unvalidated 
clinical decision 
rule. 
SR/meta-
analysis of 
lower quality 
studies or 
studies with 
inconsistent 
findings 
SR/meta-analysis of lower 
quality clinical trials or of 
study with inconsistent findings 
Lower quality clinical trial. 
Cohort study 
Case-control study 
SR/meta-analysis 
of lower quality 
cohort studies or 
with inconsistent 
results. 
Retrospective 
cohort study or 
prospective 
cohort study with 
poor follow-up. 
Case-control 
study 
Case series 
Level 3: other 
evidence 
Consensus guidelines, extrapolations from bench research, usual 
practice, opinion, disease-oriented evidence (intermediate or 
physiologic outcomes only), or case series for studies of diagnosis, 
treatment, prevention, or screening). 
Ebell, et al. (2004). Strength of recommendation taxonomy (SORT): a patient-centered 
approach to grading evidence in the medical literature. American Family Physician, 
69(3), pg. 548-556.  Retrieved from: http://www.aafp.org/afp/2004/0201/p548.pdf 
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Table 2. Summary Review of Articles 
Depression Screening in the Primary Care Setting 
Author & Year Type of 
Literature 
Design 
Sample Purpose of 
Article 
Findings Implications Evidence 
Level 
Comments 
(Cashman, Hale, 
Candib, 
Nimiroski, & 
Brookings, 
2004) 
Non-
randomize
d control 
trial 
207 
Patients 
 
117 
patients + 
for one or 
both 
questions 
 
Of the 117, 
100 scored 
positive for 
depression 
To evaluate 
the pilot 
study of a 
depression 
screening 
and 
treatment 
program. 
Training 
required for 
medical 
staff and 
nurses. 
 
Initial use 
of 2 
question 
screen 
 
If + 
completed 
CES-D  
 
Screened 
small 
number of 
red flag” 
patients 
Must address 
challenges: 
limited, time, 
and staff. 
Level 2 In the 
conclusion, 
decided the 
2 questions 
would have 
been helpful 
on the 
encounter 
form before 
the patient is 
seen. 
(Farrell et al., 
2009) 
Non-
randomize
d control 
trail 
20 person 
convenienc
e sample 
To evaluate 
the 
implementa
tion of e-
screening 
in a rural 
population. 
7 % of 
participants 
had no 
depression. 
 
25% mild, 
20% 
moderate, 
10% 
moderately 
severe, 0% 
severe 
depression 
 
Reported 
easy use of 
e-screening 
Electronic 
screening is 
efficient and 
accurate in 
screening for 
depression. 
 
Level 2 Use of PHQ-
9 
Gilbody, House, 
& Sheldon, 
2009) 
Systematic 
Review 
Twelve 
studies 
-9 in 
primary 
care 
-2 
outpatient 
-1 elderly 
inpatient 
setting 
 
Patient 
screened 
regardless 
of risk 
versus 
high-risk 
patients 
 
Effectivene
ss of use of 
screening 
tool on 
detection 
and 
manageme
nt of 
depression 
Conflicting 
data with 
minimal 
improveme
nt in 
regards to 
patients 
risk for 
depression 
or provider 
notification
. 
 
Difficulty 
differentiati
ng 
screening 
versus 
interventio
States limited 
support for 
depression 
screening 
Level 1 Cochrane 
review 
Limited 
evidence to 
support 
screening 
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Interventio
ns included 
provider 
notified or 
not of 
screening 
score 
n effect on 
improved 
screening 
scores 
(O’Connor, 
Whitlock, 
Gaynes, & Beil, 
2009) 
Systematic 
Review 
1 RCT (n= 
969) 
addressing 
screening 
effects on 
mortality 
and 
morbidity 
 
8 RCTs 
(n=1908) 
addressing 
clinical 
feedback 
and 
remission 
of 
depression 
 
Unknown 
number 
articles to 
rule out 
adverse 
effects 
related to 
screening 
To update 
literature 
related to 
USPTF’s 
statement 
supporting 
depression 
screening 
Minimal 
improveme
nt on 
mortality or 
morbidity. 
 
Difficulty 
in 
generalizin
g 
improveme
nt in 
depressive 
symptoms 
related to 
provider 
feedback 
due to 
limited 
power in 
sample 
size. 
Due to no 
adverse effect 
finding, 
USPSTF 
continues to 
recommend 
depression 
screening 
with staff-
supported 
resources in 
place. 
Level 1 Primary 
focus on 
staff-
supported 
resources. 
(Richardson & 
Puskar, 2012)  
Expert 
Opinion 
N/A Educate 
providers 
on brief 
depression 
screening 
and 
assessment 
methods. 
PHQ-2 and 
PHQ-9- 
quick, 
effective, 
and tested 
in primary 
care 
settings.  
PHQ-9 may 
be used to 
tracking 
outcomes.  
 
All positive 
screenings 
require 
diagnostic 
interviewing 
or referral. 
 
Level 3 Barriers to 
screening- 
limited time, 
uncertainty 
regarding 
tool, limited 
follow-up 
plan. 
 
(Roman & 
Callen, 2008) 
Expert 
Opinion 
and 
Extrapolati
ons from 
research. 
N/A To 
education 
providers 
on 8 
depression 
screening 
tools 
All are 
appropriate 
screening 
tools for 
depression: 
Geriatric 
Depression 
Scale 
(GDS), 
GDS-15, 
Center for 
Epidemiolo
gic Studies 
Depression 
Scale 
(CES-D), 
Recognizing 
symptoms is 
first step in 
preventing 
suicide. 
 
Provider 
treatment 
plans, or 
referral plans 
must be 
outlined. 
Level 3 N/A 
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CES-D 
Short 
Form, 
Hamilton 
Depression 
Scale, Beck 
Depression 
inventory, 
PHQ-9, 
Cornell 
Scale for 
Depression 
in 
Dementia 
(Schmitt, Miller, 
Harrison, & 
Touchet, 2010) 
Qualitative 
Study 
14,736 
physician 
office 
visits 
To evaluate 
the increase 
in office 
visit 
duration 
due to the 
addition of 
depression 
screening. 
Depression 
screening 
significantl
y increased 
the 
duration of 
the office 
visit. 
 
 
Methods to 
increase 
efficiency and 
decrease time 
screening 
must be 
evaluated. 
 
Different 
technologies 
to make 
screening 
easier are 
needed- such 
as 
computerized 
screening,  
Level 2 Must 
continue to 
assess 
barriers: 
must have 
plan in place 
to treat or 
refer 
patients 
once 
diagnosed. 
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Guideline Analysis: Adult Depression in Primary Care 
The National Institute of Mental Health (2011) defines depression as a serious 
illness in which the symptoms interfere with all aspects of an individual’s life.  
Individuals experiencing depression experience lack of interest in pleasurable things, 
weight loss or gain, insomnia or excessive sleeping, fatigue, decreased ability to 
concentrate, and thoughts of suicide (American Psychological Association, 2013).  
Depression is estimated to affect 350 million people worldwide and is the leading cause 
of disability (WHO, 2012).  In the United States, approximately 1 in 10 people currently 
experience depressive symptoms (CDC, 2012), and the cost of depression in the U.S. is 
as high as $44 billion (CDC, 2013).   
The ultimate cost of depression, is that of a person’s life.  In 2004 the CDC 
ranked suicide as the 11th leading cause of death (CDC, 2012).  In 2007, Mental Health 
America (MHA) reported rankings for each state and the District of Columbia regarding 
their depression and suicide rates, and the overall mental health of each state.  The overall 
mental health of Kentucky was ranked by the MHA (2007) as 49th (out of 51 states and 
the District of Columbia).  According to 2004-2005 data, 8.5% of Kentucky adults 
suffered from a major depressive episode and suicide rates in Kentucky ranked 34th in the 
country.    
Depression is an important issue in Kentucky and the nation.  Due to its high 
importance national evidence-based guidelines and recommendations have been created 
to support providers in the practice of screening for depression and to help guide 
providers in correctly identifying depression.  The purpose of this paper is to analyze the 
guideline Adult Depression in Primary Care.  The developing organization of this 
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guideline was the Institute for Clinical Systems Improvement (ICSI).  This guideline was 
last revised in September 2013.  The overall objective of this guideline was to inform 
providers about effective assessment, diagnosis, and treatments of adults diagnosed with 
depression, as well as increase the percentage of patients accurately diagnosed with 
depression (Mitchell et al., 2013). 
Stakeholder Involvement 
 The ICSI is a nonprofit organization sponsored by five Minnesota and Wisconsin 
non-profit health plans.  When developing guidelines ICSI utilizes a multidisciplinary 
work group of medical professionals.  To develop guidelines, work groups are created 
with 6-12 individuals who are knowledgeable about the topic.  The work group for this 
particular guideline included physicians, pharmacists, psychologists, psychiatrists, and 
nurse practitioners (Mitchell et al., 2013).  In the interest of full disclosure the individual 
organizational affiliations of each group member were provided.  However, many 
national organizations such as the American Psychological Association or the American 
Academy of Family Physicians were not named, although these individuals may be 
members of larger organizations.  Also credentials for each work member were provided 
but lacked explanation of specific experience related to caring for patients with 
depression.   
Rigor of Development 
 To evaluate the evidence to inform the guideline development, a literature search 
was divided into two phases: the first stage identified systemic reviews, while the second 
phase identified randomized control trials, meta-analyses, and other literature (Mitchell et 
al., 2013).  The authors did not list which databases were utilized for this literature 
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search.  At the completion of the literature search the work group ranked the evidence.  
ICSI utilized the GRADE methodology where the quality of the evidence was rated as 
high, moderate, or low depending on the likelihood further research would change their 
recommendations (Mitchell et al., 2013).  Using the GRADE methodology, the work 
group formulated their recommendations based on the overall review of the evidence.  An 
overall rating of the literature was not provided, however guideline grades were provided 
for each individual reference cited. 
 The guideline Adult Depression in Primary Care provided many 
recommendations including screening, diagnosis, treatment options, and follow-up care 
for those with depression.  Mitchell et al. (2013) supported the use of the Patient Health 
Questionaire-9 (PHQ-9) by presenting meta-analyses, systematic reviews, and many 
references they graded as low-level evidence.  In addition to the use of the PHQ-9, the 
authors recommended further assessment of the patient to include past medical history, 
co-morbidities, substance use, and the safety of the patient and others, supported by a 
multitude of evidence ranging in meta-analyses, references graded as high-evidence, 
systematic reviews, and what the work group deemed as low-quality evidence.  
Recommendations for cultural considerations, special populations (geriatrics, patients 
with cognitive impairment, and perinatal patients), had the same variety of evidence 
levels as other recommendations presented, ranging from high-evidence, to specific types 
of studies like meta-analysis and systematic reviews, and also included low-quality 
evidence.   For the diagnosis of depression the criteria from the DSM-IV and the 
American Psychiatric Association Guideline were outlined within this guideline and 
included to discuss evidence-based treatment and follow-up plans. 
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 Overall, the recommendations were appropriate for the supporting evidence.  The 
authors of the guideline provided an extremely comprehensive review and synthesis of 
literature.  Each individual recommendation had the foundation of sound evidence, and a 
provider could rely on the recommendations of this guideline.  Lastly, the procedure for 
updating the guideline was specifically explained.  Mitchell et al. (2013) explained 
revisions occurred every 12-24 months dependent on changes within the literature and 
practice.  Each of the work group members remained current on the literature by 
reviewing peer-reviewed journals and meeting with the work group during and at the end 
of the guideline cycle (Mitchell et al., 2013).  With each revision, the guideline must be 
approved by the ICSI Committee on Evidence-Based Practice, which was comprised of 
medical providers and nurses representing the ICSI member organizations within the 
United States (Mitchell et al., 2013). 
Clarity and Presentation 
In Adult Depression in Primary Care (Mitchell et al., 2013), the key 
recommendations were easily identified within the algorithm and were available to assist 
providers in the screening, diagnosis, treatment, and follow-up for patients with 
depression.  These recommendations included the use of the PHQ-9 or other identified 
screening tools when patients were suspected or presented with depressive symptoms 
(Tragel et al., 2013).  Tragel et al., (2013) also specifically detailed the DSM-IV criteria 
for diagnosing depression, as well as guided providers in the clinical interview to include 
history of present illness, co-morbidities, substance abuse, and current medications.  It 
was then recommended the clinician assess if the patient diagnosed with depression is 
unsafe to themselves or to others (Tragel et al., 2013).   
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The guideline recommended utilizing patients’ PHQ-9 score to assist with 
potential treatment options, as shown in the table below. 
PHQ-9 Score Depression Severity Treatment 
Recommendations 
5-9 Mild Depressive Symptoms  Exercise 
 Behavioral 
activation 
 Call provider if 
symptoms worsen.   
 No improvement in 
1-2 months, contact 
mental health 
provider. 
10 -14 Mild Major Depression  Above 
interventions 
 Begin 
pharmacotherapy or 
psychotherapy 
 Weekly contact 
initially, decreased 
to monthly follow-
up 
15-19 Moderate Depression  Above 
interventions 
 Weekly contacts, 
bi-monthly follow-
ups, then finally 
reduced to monthly 
Scores ≥ 20 Severe Major Depression  Above 
interventions 
 Weekly follow-ups 
until symptoms 
lessen in severity 
Table 1. Depression treatment recommendations (Mitchell et al., 2013) 
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The above recommendations are specific and unambiguous.  The specificity of the 
recommendations can be shown in the recommendation for diagnosing depression with 
the use of the clinical interview.  Mitchell et al. (2013) provided the detailed explanation 
of the DSM-IV criteria required for a diagnosis of depression.  They also provided to a 
mnemonic SIGECAPS to help providers remember the symptoms of depression, which 
include sleep disorder, interest deficit, guilt, energy deficit, concentration deficit, appetite 
disorder, psychomotor retardation or agitation, and suicidality.  The authors also 
provided explanation of differential diagnoses such as anxiety or somatoform disorder, 
adjustment disorder, and bipolar disorder. 
 The variety of treatment options were explained in detail as well as a comparison 
of psychotherapy versus pharmacotherapy.  Mitchell et al. (2013) provided evidence to 
support the use of various psychotherapies including cognitive behavioral therapy, 
interpersonal therapy, short-term psychodynamic psychotherapy, and problem-solving 
treatment.  Complementary and alternative therapy including acupuncture and herbals 
were also discussed within the guideline.  In regards to pharmacotherapy, the use of 
selective serotonin reuptake inhibitors as the first-line treatment was discussed.  Alternate 
pharmacotherapy options included the use of secondary amine tricyclics, monoamine 
oxidase inhibitors, and atypical antipsychotics.  The guideline stressed the importance of 
choosing the right medication depending on the patient’s response to previous treatment, 
patient preferences, medication side effects, availability, costs, drug-drug interactions, 
and safety.  Proper administration of pharmacotherapy along with potential side effects 
was also discussed in detail. 
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Application 
 When discussing potential organizational barriers, Mitchell et al. (2013) discussed 
barriers ranging from implementing a screening program to the potential barriers in the 
patient’s care.  For caring for the patient with depression, the first recommendation was 
to assess the current organizational culture in regards to depression screening and 
treatment.  This assessment included the evaluation of a need for a shift in the 
organizations beliefs, values, and behaviors (Mitchell et al., 2013).  Other potential 
barriers listed included the necessity of training staff, the implementation of the 
recommended collaborative care model, and creation of patient education and self-care 
management materials (Mitchell et al., 2013).  With the recommendation of the 
collaborative care model, which encouraged the use of a mental health specialist, this 
may present a barrier such as in rural areas where mental health specialists may be scarce 
(Mitchell et al., 2013).  To assist in overcoming potential barriers and provide educational 
resources, the authors of the guideline provided a variety of resources and tools that 
addressed comorbidities, cultural considerations, drug interactions, electroconvulsive 
therapy, professional organization resources, governmental resources such as databases, 
and perinatal resources (Mitchell et al., 2013). 
 The authors of the guideline also briefly discussed potential cost implications of 
applying the recommendations included in the guideline.  The discussion of cost 
implications focused on the implementation of a collaborative care model.  Mitchell et 
al., (2013) provided evidence that suggested an increased cost to the care system for the 
first year, but a potential turn in cost in the second year.  The authors list the only long-
term study, the IMPACT study, which showed a cost savings of $3,363 per patient over 
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the four year period (Unutzer, 2008).  
Editorial Independence 
 ICSI provided an explicit statement stating the organization did not influence the 
guideline development.  The statement acknowledged the work group was not paid by the 
organization and all the recommendations were based on the independent evaluation of 
the evidence by the work group (Mitchell et al., 2013).  Conflicts of interest were also 
specifically listed.  Mitchell et al., (2013) shared every work group member along with 
the presence or absence of potential conflicts of interest.  For each work group 
participant, the conflict of interest section specifically listed job titles, department, 
affiliated organizations; local, regional, and national committee affiliations; guideline 
related activities; research grants; and finally financial and non-financial conflicts of 
interest.  Those with potential financial conflicts of interest specified an estimated dollar 
amount.  Of the nine work group members, only one listed financial and non-financial 
conflicts of interest which included being a lecturer for the University of Minnesota, and 
stock holdings with two pharmaceutical companies. 
Comparison of Other Guidelines 
 Other depression screening guidelines that are available include the Veteran 
Affairs and Department of Defense clinical practice guideline for management of major 
depressive disorder (2009) and the American Psychiatric Association (APA) guideline 
Practice Guideline for the Treatment of Patients with Major Depressive Disorder  (2013).  
The Department of Veterans Affairs (VA) and Department of Defense (DOD) created a 
guideline related to the screening, diagnosis, and treatment of major depression.  Their 
explanation of the method used to retrieve evidence is more detailed in the use of a 
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PICOT question, provided a list of the databases that were searched, as well as a more 
detailed inclusion criteria.  The Department of Veteran Affairs inclusion criteria were 
English studies performed in the U.S., United Kingdom, Europe, Australia, Japan, and 
New Zealand (Department of Veteran Affairs, Department of Defense, 2009).  The 
evidence provided from the literature review was also rated by the strength of evidence, 
the scheme used was provided. 
The American Psychiatric Association (APA) published the third edition of their 
guideline Practice Guideline for the Treatment of Patients with Major Depressive 
Disorder in 2010.  This guideline was revised by an APA work group that reviewed 
literature published after the year 2000, which allowed the work group to review 
literature published after the second edition of this guideline.  The work group created 
evidence tables with the current literature to evaluate its strength.  Recommendations 
made in this guideline underwent both internal and external work group peer review. 
Overall, the recommendations are very similar between the Department of 
Veteran Affairs and Department of Defense guideline and the APA guideline when 
compared with the ICSI guideline.  The Department of Veteran Affairs and Department 
of Defense guideline also recommended the use of the PHQ-9 (2009), whereas the APA 
guideline did not specifically recommend one screening tool over another.  The VA/DOD 
guideline also evaluated the evidence in regards to different populations such as the 
elderly and post-partum women (2009).  Recommendations were also made for a detailed 
evaluation that included history of present illness, comorbidities, the current use of 
medications, and substance abuse (VA/DOD, 2009).  As with the ICSI guideline, the 
VA/DOD explained the symptoms of differential diagnoses which include bipolar 
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disorder, substance use disorder, depression not otherwise specified, and dysthymia 
(2009).  The Department of Veteran Affairs and Department of Defense and the APA 
guideline recommended and explained very similar treatment options as ICSI; which 
included detailed explanation of psychotherapy and pharmacotherapy.  Also included in 
the VA/DOD guideline is a more detailed discussion of self-management strategies 
which include nutrition, exercise, sleep hygiene, tobacco use, caffeine use, alcohol use 
and abuse, and pleasurable activities (2009).  One topic the VA/DOD addressed that the 
ICSI guideline did not, is that of psychosocial issues including housing, finances, 
problematic relationships, social support, spiritual issues, occupational problems, 
difficulties with activities of daily living, and other potential stressors (2009).  The APA 
guideline also coincided with the ICIS guideline by stressing the importance of a 
collaborative effort in regards to the treatment of a patient with depression. 
Although the three guidelines addressed were very similar, the ICSI guideline 
might be considered superior due to the recommendations guided specifically to primary 
care, and the use of the screening and treatment algorithm.  Algorithms allow for 
providers to have a simple and fast guide in assessing and diagnosing depression.  
Algorithms may also help the provider quickly remember steps that may have otherwise 
been forgotten or skipped.  The presentation of the ICSI guideline along with the 
foundation of evidence allows for providers to have confidence in this guideline and its 
recommendations.  The ICSI guideline also is focused on primary care and encourages 
the use of collaborate efforts in regards of the patient.  
 This author recommends the utilization of this guideline by nurse practitioners 
due to the ease of the screening and treatment algorithm and foundation of guideline as 
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evidence-based.  Recommendations for this guideline could also be made to the 
investment and resources ICSI has in the revision process of the guideline.  Providers can 
be confident this guideline has more current evidence in comparison to the older 
VA/DOD guideline whose last updated version was released in 2009.  Guidelines such as 
ICSI enables a more efficient transition of evidence from research to practice, enhancing 
the care provided by nurse practitioners and other healthcare providers 
Conclusion 
 In the primary care setting, the knowledge foundation a provider must maintain is 
extremely large.  The use of guidelines and recommendations facilitates the nurse 
practitioner and other providers to provide the most up to date care to their patients as 
possible.  However many guidelines and recommendations are available and providers 
must be able to quickly analyze the quality of the guideline as well as the organization or 
group that is providing the recommendations. Based on the above analysis, this author 
recommends the use of the guideline Adult Depression in Primary Care, as the most 
current and most appropriate for the use of depression screening and treatment in the 
primary care setting.   
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Depression Screening in Primary Care: A Practice Inquiry Project 
 
Depression knows no boundary and is estimated to affect 350 million people 
worldwide and is the leading cause of disability (WHO, 2012).  The Center for Disease 
Control (CDC) reported 8% of the U.S. population age 12 years or older report current 
depression (2012).  The American College Health Association (ACHA) has performed the 
National College Health Assessment twice each year.  In the spring of 2013, the ACHA 
released the results of data on 123,078 participants aging 18 years and older.  Of these 
participants, 45% (n=55,385) stated they “felt things were hopeless”, 55% (n=67,747) “felt 
very lonely”, and 31.3% (n=38,523) “felt so depressed it was difficult to function”.  The 
ultimate cost of depression is that of a person’s life.  In 2004 the CDC ranked suicide as the 
11th leading cause of death in adults 18 years and older (CDC, 2012).  The American 
College Health Association (2013) found among college students in the last 12 months, 
7.4% (n=9,107) seriously considered suicide, 5.9% (n=7,261) intentionally cut, burned, 
bruised, or otherwise injured themselves, and 1.5% (n=1,846) attempted suicide (Table 1). 
Depression in College Age Students 
In the last 12 months National College 
Health Assessment 
(2013) 
UK 2013 
Health 
Behavior Study 
(J. Brown, personal 
communication, April 
30, 2013) 
LGBT Statistics 
at UK 
(J. Brown, personal 
communication, April 30, 
2013) 
Considered Suicide 7.4% 7.7% 24% 
Made A Plan (no data available) 5% 27% 
Attempted Suicide 1.5% 0.9% 6% 
Intentionally Harmed 5.9% 5.7% 19.4% 
Table 1. Depression in College Age Students  
 
In 2013, the University of Kentucky conducted a Health Behavior study focusing 
on stress and coping behaviors among 151 college students, 17 years or older; statistics 
related to suicide ideation and self-injury at the University of Kentucky were very similar 
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to the national average.  As seen above in Table 1, the statistics were significantly higher in 
those students who identified on the lesbian, gay, bisexual, transgender (LGBT) spectrum.  
Unfortunately, the ACHA National College Health Assessment did not further stratify the 
results into students identifying on the LGBT spectrum.  The rates of students struggling 
with depression and thoughts of harming themselves, should compel providers to provide 
depression screening and treatment among college age students. 
Screening for depression in primary care has been supported by the World Health 
Organization, the U.S. Preventive Services Task Force, and the American Academy of 
Family Physicians (AAFP).  The AAFP and U.S. Preventive Task Force both recommend 
in clinics with the capability to treat depression, adults 18 years and older should be 
screened for depression at every visit.  The Institute for Clinical Systems Improvement 
developed a guideline titled Adult Depression in Primary Care (Mitchell et al., 2013) to 
assist providers in the assessment, diagnosis, and treatment of depression. 
Despite these statistics and guidelines, many providers struggle to implement 
depression screening.  A literature review found many validated screening tools are 
available but the primary barrier to depression screening was the limited resources 
available to providers, limited time providers have for appointment times, number of 
trained staff available to perform screening, and the variety of depression screening tools.  
It has been shown depression screening does increase the duration of office visits by an 
average of 6 minutes if a depression screening tool was administered by a nurse and scored 
by a physician (Schmitt, Miller, Harrison, & Touchet, 2010).   
To overcome this particular barrier, studies have been performed to look at the use 
of different technologies for screening, such as a computer-based approach, or on the sign-
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in forms for the patients to allow for faster screening (Farrell et al., 2009; Fann et al., 
2009).  Fann et al. (2009) utilized electronic registration to screen patients for depression.  
Initially, the patients were quickly screened using the PHQ-2, if either question was 
answered positively, the following seven questions of the PHQ-9 would be triggered.  The 
average reported time to complete the PHQ-9 screening was two minutes (compared to six 
minutes found by Schmitt, Miller, Harrison, & Touchet).  The guideline, Adult Depression 
in Primary Care, further recommends screening for depression via the PHQ-9, and further 
assists providers to efficiently provide further evaluation and treatment to continue to 
decrease patient appointment times (Mitchell et al., 2013).   
 Evidence from the literature raises multiple questions: how often do providers 
currently screen for depression?, will electronic screening tools at intake improve attention 
to and documentation of depression screening by clinicians?, and would education 
provided to clinicians about depression screening and available resources improve attention 
and documentation to depression screening?  Thus the purpose of this study was to answer 
these questions by evaluating the implementation of a depression screening program at a 
large public university student health clinic utilizing patient charts and a provider survey.  
The objectives of this study were as follows:  
 To evaluate the current frequency with which providers perform and document 
depression screening.   
 To determine the potential effect of education on the clinic’s providers’ attention to 
and documenation of depression screening. 
 To determine the potential effect a pre-administered PHQ-9 may have on providers’ 
attention to and the documentation of depression screening.  
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Theoretical Framework 
  To assist with the evaluation of the implementation of depression screening at a 
large university’s student health clinic, the Model for Evidence-Based Practice Change 
(Larrabee, 2004; & Ciliska et al., 2011) was utilized.  The Model for Evidence-Based 
Practice Change is composed of six steps used to discuss the process of implementing and 
evaluating the depression screening program.  The first step requires the assessment for a 
need for practice change.  This assessment was performed prior to the implementation of 
this study through chart reviews performed previously (by others not involved in this study) 
and clinician statements regarding the need and support of depression screening.  The 
second step in this model requires the review of the best and most current evidence.  The 
review of literature supporting this study consisted of reviewing successful depression 
screening programs at another large, public university; reviewed evidence supporting 
depression screening tools; the evidence supporting national recommendations regarding 
depression screening; and finally, literature addressing barriers to depression screening.   
The third and fourth steps of the Model for Evidence-Based Practice Change 
(Larrabee, 2004; Ciliska et al., 2011) consisted of analyzing the evidence and designing the 
practice change.  The planning of the practice change consisted of three parts.  The first 
part of the planned practice change was to evaluate the current depression screening rates at 
a large university health clinic, which was performed by performing an initial retrospective 
chart review.  The second part of the practice change consisted of a provider educational 
session regarding current depression screening rates and the planned initiation of 
depression screening within the clinic.  The final component consisted of the actual 
implementation of the PHQ-9 screening tool within the clinic.  The evidence from the 
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literature supported the use of the PHQ-9 depression screening tool in an electronic-sign in 
format (Mitchell et al., 2013; Fann et al, 2009).   
The fifth step was the focus of this study which included the implementation and 
evaluation of the change in practice (Larrabee, 2004; Ciliska et al., 2011).   Ciliska et al 
(2011) describes the smaller components of step five to include the evaluation of the post-
pilot data and verbal feedback from providers to decide if the practice change will be 
adapted, adopted, or rejected.  The sixth and final step of the model, integrating and 
maintaining the change, would be completed by the clinic after the evaluation and 
recommendations regarding the practice change have been made at the conclusion of this 
study. 
Design 
 This study consisted of a quasi-experiemental, pre-post intervention design that was 
performed in three parts.  Initially, a retrospectice chart review was performed to evalaute 
the current frequency of depression screening at a large university health clinic in the fall of 
2014.  During the winter break between semesters, a 25 minute provider educational 
session during a provider monthly meeting, was conducted to review the results of the 
initial chart review, discuss national depression screening recommendations, and to inform 
providers about the planned pilot of a depression screening program utilizing the PHQ-9 
within the electronic patient sign-in form.  After this educational session, providers were 
asked to answer a brief survey regarding the usefulness of the educational session, if the 
educational session might be useful in changing their current screening practices, and 
finally to include the two largest barriers they see to screening within the clinic.  Finally, 
the third component of the study included a final chart review, performed during the Spring 
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of 2015.  This chart review attempted to evaluate potential changes in provider’s 
performance and documentation of depression screening. 
Setting and Study Population 
The university health clinic was located on a large university campus and provided 
health services to all full-time students of the university and part-time students who paid 
the health fee or paid on a fee-for-service basis.  This clinic provided services such as 
behavioral, general, and women’s health.  The clinic was staffed by physicians, nurse 
practitioners, registered nurses, nursing care technicians, a dietician, and two health 
educators.  The university also had behavioral health and counseling services available for 
students.   
 The study consisted of two convenience samples, 1) electronic medical records of 
patients age 18 and older and 2) providers at a large university health clinic.  The clinic 
appointments consisted of patients for both acute and wellness visits.  To be included in the 
study the patient must have been 18 years or older, and had completed the annual medical 
history form at the time of sign-in.  The annual medical history form is automatically 
generated for patients to fill-out when seen in the clinic every 365 days.  This form allows 
the patients to review and updated their medical history, current medications, social history, 
and etcetera.  Patient charts were excluded from the study if patients were younger than 18 
years or had not completed the annual medical history form at the time of their visit.  
Providers were invited to participate in the study at the educational session.  Fifteen 
providers completed the informed consent forms as well as completed the anonymous 
paper survey provided at the end of the session.   
 
 
  51 
 
Method 
Initial Retrospective Chart Review 
  After receiving approval from the Institutional Review Board (IRB), the initial 
retrospective chart review was performed by systematically reviewing 116 medical records 
of patients meeting the inclusion/exclusion criteria.  Within a two week period, 
approximately 500 patients were seen at the clinic that were required to complete the 
annual medical history form.  For a quality improvement study such as this, with a 
population size of 400-500 the World Health Organization recommended a sample size of 
116 patient charts (Agins, Seung, & Heiby, 2008).  For the initial chart review, to achieve a 
sample size of 116 patient charts, the principle investigator pulled every fourth chart for 
patients seen that had completed the annual medical history form between November 10-
21, 2014.   
Provider Educational Session 
 A 25 minute educational session was conducted during a monthly provider meeting 
on February 12, 2015, after the initial chart review and before the initiation of the PHQ-9 
screening on the electronic sign-in form.  The presentation included a brief didactic portion 
followed by discussion with the providers to address any comments or concerns regarding 
the screening program.  The purpose of this educational session was to educate providers 
regarding the current depression screening practices, the PHQ-9 screening tool and its 
implementation on the electronic intake form, depression treatment options, campus 
resources available for students with depression, and depression screening practices at other 
universities.  At the end of the session, providers were asked to anonymously complete a 
brief survey evaluating the effectiveness of the session (Appendix C).  At the time of the 
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study, 15 physicians and nurse practitioners were employed in primary care at the clinic.  
Only providers employed by the university health clinic were recruited and included in this 
survey.  Exclusion criteria included other employees of the clinic such as office staff, 
certified medical assistants, and nurses. 
Post-intervention Chart Review 
After the initial retrospective chart review and provider educational session, the 
health clinic created a depression screening template utilizing the Patient Health 
Questionnaire-9 (PHQ-9), consisting of nine questions that have shown to be effective in 
screening for depression (Kroenke, Spitzer, & Williams, 2001), and the use of the PHQ-9 is 
recommended by the guideline, Adult Depression in Primary Care (Mitchell et al., 2013). 
 The university clinic had the unique ability to create templates within their 
electronic medical record on the clinician side (without having to utilize technical support).  
Originally, the PHQ-9 template was planned to included as a part of each patient’s annual 
medical history form, requiring the patients to be screened once each year.  However, prior 
to implementation the clinic opted to implement the screening template to generate every 
90 days a patient was seen in the clinic.  The clinic providers thought that the depression 
screening frequency should be increased, but yet desired a smaller proportion of students 
screened as the practice change was implemented.   
The screening template began by quickly screening patients using the PHQ-2, 
consisting of the first two questions of the PHQ-9: “in the past two weeks how often have 
you been bothered by any of the following problems? 1) little interest or pleasure in doing 
things, 2) Feeling down, depressed, or hopeless” (Kroenke, Spitzer, & Williams, 2001).  
For each question, students selected an answer ranging from 1) not at all, 2) several days, 
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3) more than half the days, or 4) nearly every day.  A positive screen (a score of 4 or more) 
occurred if the patient answered more than half the days or nearly every day to either 
question.  A postive screen resulted in asking the patient to answer the remaing seven 
questions of the PHQ-9.  Each answer of the PHQ-9 has a weighted score that totaled 
allowed the healthcare provider to quantify the depressive symptoms in terms of transient 
(score of 1-4), mild (score of 5-10), moderate (score 10-19), or severe depression (scores ≥ 
20).   
  After the patient completed the PHQ-2 or PHQ-9 the template automatically totaled 
the weighted respones, and the template with the total screening score was immediately 
sent electronically to the patient’s provider to review while the patient was being placed 
into the exam room.  If the patient had a screening score of 4 or greater, the provider could 
discuss the score with patients, print an educational handout, and send the patient one of 
two secure e-mail messages further discussing the depression screening score, severity of 
score, recommendations for further evaluation, and campus resources available to the 
student (Appendix A and B). 
  The depression screening template was initiated on Februray 16, 2015.  A second 
chart review was performed utilizing the same procedure as the intital chart review.  This 
second chart review evaluted charts of patient seen between the dates of February 16-27, 
2015.  Due to several factors discussed later in the limitations section of this paper, 
including the discontinuation of the pilot screening tool two days early, a smaller sample 
size (n=97) was utilized.  Both chart reviews gathered data including the date of visit, 
gender, age, current diagnosis of depression, current treatment for depression, if depression 
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screening was documented, the tool used for screening, depression screening score, and if 
treatment or an intervention was provided. 
Results 
Pre-intervention Chart Review 
Of the 116 charts reviewed 33.6% (n=39) were male and 66.4% (n=77) were 
female patients, with ages ranging from 18 to 34 years old and a mean age of 20.5 years.  
Upon reviewing the patient charts, 11% (n=15) patients listed a history of depression with 
4.4% (n=6) listing a current medication for the treatment of depression, and 0.7% (n=1) 
documenting current treatment of depressoin with counseling.  Despite the above, 
depression screening was not documented for any patient. 
Educational Session Survey 
Results of the anonymous provider survey which evaluted the educational session may be 
seen below in Table 2. 
Depression Educational Session Survey Results (n=15) 
Results by individual question Strongly 
Disagree 
Disagree Neutral Agree Strongly 
Agree 
The educational session 
provided new information 
regarding depression 
screening tools. 
  15.8% 
(n=3) 
42.1% 
(n=8) 
26.7% 
(n=4) 
The educational program 
provided new information 
regarding depression 
screening programs at other 
uniersity health clinics. 
  33.3% 
(n=5) 
40% 
(n=6) 
26.7 
(n=4) 
I found the educational 
program to be beneficial. 
  13.3% 
(n=2) 
53.3 
(n=8) 
33.3 
(n=5) 
The educational program 
increased awareness of 
current depression screening 
practices here at the 
univserity health clinic. 
  26.7% 
(n=4) 
40% 
(n=6) 
33.3 
(n=5) 
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The information received 
from the educational program 
made me think about the way 
I practice. 
 13.3% 
(n=2) 
33.3% 
(n=5) 
40% 
(n=6) 
13.3 
(n=2) 
The infromation motivated 
me to screen patients for 
depression. 
6.7% 
(n=1) 
 13.3% 
(n=2) 
53.3% 
(n=8) 
226.7% 
(n=4) 
How often did you think you 
were providing depression 
screening for patients? 
6.7% 
(n=1) 
6.7% 
(n=1) 
26.7% 
(n-4) 
33.3% 
(n=5) 
26.7% 
(n=4) 
Table 2. Depression Educational Session Survey Results 
 Perceived screening barriers.  At the end of the survey, providers were asked to 
list two factors that are currently impeding depression screening at the university health 
clinic.  These questions were open ended with 52.6% of the providers responding (n=10) 
that limited time for screening was the major factor hindering depression screening at the 
health clinic.  Other responses included fear of liability of the provider (10.5%, n=2), 
limited resources (10.5%, n=2), no screening tool in place (15.8%, n=3), lack of awareness 
regarding the need for screening (5.3%, n=1), and limited clinician availability (5.3%, 
n=1).  Based on the two most common barrier responses (limited time and lack of 
screening tool), the intervention was tailored to provide a valid, time efficient screening 
template utilizing the PHQ-2 and PHQ-9. 
Post-intervention Chart Review 
 The post-intervention chart review resulted in a sample size of 97 patients.  Table 3 
provides a comparison of the patient demographics and screening results of the initial 
retrospective and post intervention chart reviews.  The primary investigator did not stratify 
the demographics beyond age and gender.   
 Pre-Intervention Review Post-Intervention Review 
Charts reviewed 116 97 
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Gender 
   Male 
   Female 
 
33.6% (n=39) 
66.4% (n=77) 
 
37.1% (n=36) 
62.9% (n=61) 
Age 18-34, mean of 20.4 18-47, mean of 21.6 
Hx of depression 
listed 
11% (n=15) 6.2% (n=6) 
Current Treatment 
    Medication 
    Counseling  
 
4.4% (n=6) 
0.7% (n=1) 
 
2.1% (n=1) 
Screening 
Documented 
0% 60.8% (n=59) 
Table 3. Pre and Post Chart Review Results Comparison 
With the initiation of the PHQ-9 screening, 60.8% (n=59) charts had depression screening 
with the PHQ-9 documented.  Of the charts documenting depression screening 6.7% (n=4) 
patients had a postive depression screening with scores of 4, 6, 7, and 15.  For the patients 
with a postive screen, all four charts (100%) had documentation of discussion regarding the 
depression screening score and interventions provided.  Three (75%) of the four patient 
charts received the first secure e-mailed message (Appendix A) discussing the depression 
score, symptoms of depression, the potential need for further evaluation, and campus 
resources available for treatment.  One (25%) of the four patient charts received the second 
secure-email message (Appendix B) discussing the same information as the first letter, 
however containing more strongly worded discussion regarding suicidal thoughts and the 
need to seek immediate attention.  The secure e-mail messages were automatically sent to 
patients the day after the visit, and depended on the severity of their scores.  The messages 
were also included in the electronic medical record as documented coorespondence 
between the provider and the patient. 
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 Although not shown in the results of this study, verbal feedback from providers and 
campus resources expressed concern regarding a perceived marked increase in students 
receiving postive depression screens requiring further evaluation.  Campus resources and 
the student health clinic expressed concern regarding the increased demand and the limited 
availability of appointment times and providers for further evaluation.  Due to these 
expressed concerns, the depression screening period was ended two days early on 
Thursday, Februrary 26, 2015.   Due to the screening tool being stopped, 39.2% (n=38) of 
the charts did not have depression screening documented, which all 38 visits occurred on 
the last two days of the planned two week pilot period.  Had the screening tool been 
continued, depression screening would have been documented on 100% of the charts 
reviewed.  Although the screening tool had been stopped, the two dates were included into 
the study due to the parameters of IRB approval based on the number of days of the study. 
  When evaluating the potential effect of implementing the PHQ-9 screening tool, the 
chi-square test was utilized showing a significant association (<0.01) between the 
implementation of the PHQ-9 tool and the documentation of depression screening.  It was 
noteworthy the charts reviewed of patients in the post-intervention review without 
documented depression screening occurred on days when the PHQ-9 screening tool was 
not being used throughout the clinic (discussed further in the limitations section of this 
paper).  A second chi-square test was utilized to showing a significant association (<0.01) 
between the lack of the PHQ-9 screening tool and no documentation of depression 
screening. 
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Discussion 
 Overall, the intervention was effective in increasing the rates of depression 
screening at the university health clinic.  Initially, when presented to the providers during 
the educational session, the results of the initial retrospective chart review did not surprise 
the providers at the university health clinic.  Previous reviews had been performed with 
similar results, however using this knowledge and the Model for Evidence-Based Practice 
Change efforts were made to assist the health clinic in making a sustainable change.  
Similar to barriers listed in the literature review, in the survey providers listed limited time 
for depression screening as the primary barrier, while a second barrier listed was the lack of 
a screening tool available.  This study attempted to assist the providers at the university 
health clinic in overcoming both of these barriers. 
 In 2011, Klein, Ciotoli, and Chung performed a similar study at a large urban 
university health clinic.  The authors also utilized an electronic PHQ-2 initial screening 
with positive scores resulting in the continuation of the PHQ-9.  As a retrospective chart 
review, the authors found a 6% depression rate (similar of those nationally), with less than 
1% of those patients scoring greater than 20 with severe depressive symptoms.  Within the 
study, clinicans were able to refer to campus resources and reported no additional strain on 
the resources infrastructure, however the results showed only 35.7% of the patients with 
positive screens received any type of intervention. 
 During the planning phase of the implementation of the depression screening 
program, verbal feedback from providers at the university health clinic, behavioral health, 
and campus counseling services were sought and valued.  Initially, the electronic 
depression screening tool was planned to be used for students completing the annual health 
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history form.  The orginial annual screening frequency was thought to slowly introduce a 
practice change without burdening the campus resources such as behavioral health and the 
on campus counseling center. 
 As described above, the depression screening template began with the PHQ-2, and 
patients with a positive screen were asked to complete the remaining seven questions of the 
PHQ-9.  At the conclusion of the screening, the template automatically computed the 
patient’s depression screening score based on their responses to the PHQ-2 or PHQ-9.  
Providers were then able to review the scores prior to seeing the patient, and had the ability 
to discuss the scores, and provide a treatment or intervention as deemed necessary.  
Although this process required a slight practice change for the providers, the intention was 
to create a screening tool that was placed within the current workflow of the clinic reducing 
the additional efforts of the provider to screen and compute scores.  The use of the 
electronic sign-in form was also an attempt to limit the amount of time required for 
screening, as previous studies demonstrated a varying time of two to minutes to screen 
electronically (Fann et al., 2009) compared to the six minutes to screen utilizing various 
methods of paper or staff-assisted screening tools found by Schmitt, Miller, Harrison, & 
Touchet (2010).  This study did not specifically evaluate the time spent by patients or 
providers screening and addressing scores, as the retrospective chart review design did not 
allow for time measurement. 
 Not only was the time used to screen a patient for depression a voiced concern, but 
additional time required to discuss depression screening scores, treatment, and 
interventions was also discussed.  In an attempt to reduce the necessary time, the health 
clinic created a depression screening handout that could be printed at the time of the visit, 
 
  60 
 
as well as two different letters that could be securely emailed to the patient the day after a 
positive screen.  As discussed earlier, the first letter (Appendix A) was created for patients 
with mild to moderate depression scores (scores between five and nine).  This letter 
discussed symptoms of depression, campus and community resources, and addressed 
suicidal ideation.  The second letter (Appendix B), was designed for scores suggesting 
moderate to severe depression (scores greater than 10), which presented the same 
information as the first letter, but was more strongly worded to stress the need for further 
evaluation.  Again, actual time reduction with the use of the depression screening handout 
or e-mails was not able to be gathered by utilizing the chart review design of this study, and 
remains an area for further study.  The clinic stakeholder and primary investigator created 
these documents in an effort to guide and provide the provider and patient with 
supplemental materials to ease the transition of the intervention. 
 Comparing the pre-intervention and post-intervention depression screening 
frequencies, there was a statisitcally significant increase in depression screening after the 
PHQ-9 screening tool was implemented.  The screening tool was piloted for a two week 
period from February 16 to Februrary 27, 2015.  However as discussed previously due to 
increased concern regarding limited the availablility of resources, the screening tool was 
ended two days earlier than planned.  This study provided only four positive screens of the 
patients completing the annual health history form.  However, with the clinic’s decision to 
change the screening frequency from using the annual health history from to screening 
every 90 days, the new template automatially screened every patient seen at the university 
health clinic in that two week period.  Anecdotally, the clinic providers voiced concerns of 
much higher postive screening rates (greater than 20% postive screens) than shown in the 
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results of this study.  The difference in the positive screening rates occurred due to the 
continued use of the annual health history form as the inclusion criteria for the study.  The 
annual health history form was continued to be used to provide a more detailed picture of 
the patient population and to remain consistent with patient selection and remain compliant 
with the IRB approved chart selection methods.  Further studies could be performed to 
assess the postive depression screening scores of the all patients seen at the clinic during 
the pilot time period.  Also, studies could attempt to look further into college majors, class 
(freshman, sophmore, junior, senior, graduate student), and sexual orientation.  Due to the 
results of the UK 2013 Health Behavior survey, further evaluation of depression and sexual 
orientation would be beneficial. 
 The two dates that the screening tool was on hold were included in this study 
originally to evaluate potential changes in depression screening if no tool was active within 
the workflow of the provider.  Interestingly, although depression screening was a hot topic 
of discussion surrounding the implementation of the screening program, upon the 
discontinuation of the screening tool, it was noted by the primary investigator that of the 
charts reviewed for February 26-28, 2015, no depression screening was documented.  The 
difference in depresison screening while the tool was operational versus when the tool was 
discontinued was statistically significant.  This supports the need for a simple tool that may 
be seemlessly incorporated into the provider’s workflow to assist in screening patients for 
depression. 
 However, this also supports a larger issue: resource utilization.  The primary reason 
the screening tool was stopped, was due to the concern of the demand the number of 
postive depression screens placed on campus resources.  Both the behavioral health and the 
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campus counseling center quickly filled all appointment times, with the next available 
appointments stretching into a two to three week window. The decreased appointment 
availability created concern regarding the ability to further evaluate and treat students in a 
timely and appropriate manner.   
 Studies reviewing depression screening have shown the importance of only 
providing depression screening when staff-supported resources are in place to allow for 
further evaluation, treatment, and follow-up (O’Connor, Whitlock, Gaynes, & Beil, 2009; 
Gilbody, House, & Sheldon, 2009), while the USPTF recommendation statement 
categorizes depression screening with support a Grade B, however without support the 
recommendation drops to a Grade C (USPTF, 2009).  Although unintended, the most 
important outcome of this study was the fact that regardless of thoughtful planning, 
stakeholder buy-in, and the best of intentions, without the resources to further care for the 
patient, screening for depression is futile and creates the potential for liability. 
Limitations 
 One limitation to the generalizability of this study was the small sample sizes for 
both the pre-intervention and post-intervention chart reviews.  The post-intervention chart 
review sample size was smaller than desired due to several uncontrollable factors.  The first 
factor lending to the smaller sample size was due to weather as classes were cancelled for 
four days and the clinic was closed for a day during the two week pilot period.  This limited 
the patients who were on campus or who were able to be seen during the two weeks the 
screening tool was operational. 
 Another limitation to the study was the use of the annual medical history form as 
the sole template for inclusion criteria.  After the initial planning period and IRB approval, 
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the providers at the health clinic desired a more frequent screening than annually and opted 
to use a template that automatically generated every 90 days.  Although the 90-day 
screening template screened every patient initially seen in that two week period, using the 
annual medical history form for inclusion limited the number of charts reviewed that 
potentially could have shown a greater presence of depression in the patient population. 
 A final limitation of the smaller sample size was the early discontinuation of the 
depression screening tool.  Providers at the health clinic and the campus resources voiced 
concerns regarding a noticed increase in the demand of services during the screening 
period. Although, not depicted in the results of this study, the health clinic made the 
decision to hold the screening tool until after the results of this study were analyzed and 
revisions to the practice change could be made (step 4 and 5 of the Model of Evidence-
Based Practice). 
Application 
 The results of this study may be used for this particular student health clinic to 
conduct a further needs assessment to improve resources for patients with positive 
depression screens.  Discussions are currently being focused on improving the referral 
system to behavioral health providers and the campus counseling center.  Further support 
staff such as social workers and additional registered nurses may be shown to be beneficial 
in the further evaluation and education of patients that may receive a new diagnosis of 
depression. 
 The study may also be applied to assist in the implementation of depression 
screening in other university health services and in primary care clinics.  The results of the 
2013 University of Kentucky Health Behavior Study and the pre-intervention chart review 
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supports the need for screening patients for depression at a university student health clinic.  
However, the results of this study can more importantly be used to stress the importance of 
having the necessary resources in place to provide further evaluation, treatment, and 
follow-up for the patients with a positive screen as recommended by the evidence-based 
practice guidelines.   
Conclusion 
 Many university health and primary care clinics have difficulty with depression 
screening.  With an increased patient load and limited appointment times, many providers 
are hesitant to add yet another time consuming task to the appointment.  To implement a 
depression screening program, clinics must be able to have a system in place to 
appropriately evaluate and treat a diagnosis of depression.  Clinics must also assess their 
individual practice and plan a program that may be as seamless as possible within their 
workflow as well as limit the amount of time required for screening.  The depression 
screening program described above discussed one potential program that may be utilized 
by clinics for successful screening.   
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Screening for depression in primary care has been supported by the World Health 
Organization, the U.S. Preventive Services Task Force, and the American Academy of 
Family Physicians (AAFP).  The AAFP and U.S. Preventive Task Force both recommend 
in clinics with the capability to treat depression, adults 18 years and older should be 
screened for depression at every visit.  However, many barriers inhibit the implementation 
of depression screening in primary care offices such as limited time available to providers 
and the lack of a depression screening program; however the largest barrier in practice is 
that of limited resources.   
This practice inquiry project discusses the strategy one university student health 
clinic utilized in piloting a depression screening program.  Manuscript one evaluated the 
current literature related to the potential barriers of depression screening, available 
screening tools, and attempted to review screening programs that have been successfully 
implemented.  Manuscript two analyzed the guideline Adult Depression in Primary Care 
that was used as the foundation for the planning of the depression screening program 
implemented in manuscript three.  Manuscript three described the planning, 
implementation, and evaluation of a depression screening program piloted at a large 
university student health clinic.  The findings of the project showed a significant increase in 
depression screening when a depression screening tool was placed within the workflow of 
the practice setting.  However, the most significant findings occurred when resources had 
been exhausted and the screening tool was not in place; thus providing additional evidence 
to support national guidelines recommending depression screening only when the clinic has 
the ability to further evaluate, treat, and provide follow-up care.  Further work is necessary 
to assist the clinic in maintaining the depression screening program. 
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Appendix A. Depression Letter 1 
Dear Student, 
At your recent visit to University Health Services you completed a questionnaire about 
depression during the electronic sign-in process.  Based on the answers you provided, you 
may be experiencing a period of mild depression.   
What is Depression? 
Depression is a condition in which you might feel sad, hopeless, or have a decreased 
interest in activities of daily life.  Everyone has times when they feel sad or blue, however 
if you experience these feelings for 2 weeks or more, it may be depression. 
What are the symptoms of depression? 
 Irritability 
 Difficulty falling asleep, staying asleep, or sleeping too much. 
 Changes in appetite and weight 
 Changes in energy level, usually a decreased energy, but may be periods of feeling 
overexcited 
 Decreased sexual desire 
 Difficulty concentrating or remembering things 
 Feeling hopeless 
 Not caring about anything 
 Unexplained physical symptoms 
 Thoughts about death or suicide 
*Sometimes other conditions may mimic depression; a healthcare provider can help you 
find the cause for your symptoms.  
How is depression diagnosed? 
Your clinician or a mental health therapist can tell you if your symptoms may be related to 
depression.  The University of Kentucky offers several resources that may help you during 
this time. 
 UHS Behavioral Health Clinic may provide you with further evaluation and 
treatment 
o Call 323-5511 to make an appointment 
        UK Counseling Center: Consultation and Psychological Services 
o   http://www.uky.edu/StudentAffairs/Counseling/index.html 
o   Eligibility:  Students enrolled and paying for a minimum of 6 credit-
bearing hours in the current semester are eligible for an Initial Assessment 
which may lead to recommendations for services at UKCC and/or other 
providers.  (UKCC services are not extended to residents, post-doctoral 
fellows, or those enrolled solely via the Employee Education Program 
benefit.)  For summer eligibility, please see the website or call for 
information. 
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o   Call 859-257-8701 or go to 201 Frazee Hall to make an appointment M-F 8 
a.m. - 4:30 p.m. or walk in M-F 9 a.m. - 3 p.m. to be seen same-day as 
availability allows. 
 Other local resource in Lexington 
o Comprehensive Care – 1351 Newtown Pike, Lexington, KY 
 Call 859-253-2737 for an appointment 
If you have a healthcare provider at home, they may also be able to offer further evaluation 
and assistance. 
What can you do? 
 Call UHS or your regular healthcare provider if you are concerned about these 
symptoms. 
 If you have thoughts of hurting yourself or others call 911 immediately 
o Please do not wait to talk, someone can help! 
o National Suicide Prevention Lifeline 1-800-273-TALK (8255) 
 Maintaining a healthy lifestyle may reduce the symptoms of depression 
o Exercise at least 20 minutes every day 
o Learn which activities make you feel better and do them often 
o Talk to your family and friends  
o Eat a healthy diet 
o Limit intake of caffeine 
o Get 7 to 9 hours of sleep per night 
o Do not abuse alcohol or drugs 
o Learn ways to lower stress, such as breathing exercises or relaxation. 
 
Zieman, G. (2009). Depression: its symptoms and treatment.  Relayhealth. 
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Appendix B. Depression Letter 2 
Dear Student, 
At your recent visit to University Health Services you completed a questionnaire about 
depression during the electronic sign-in process.  Based on the answers you provided, you 
may be experiencing a period of moderate or severe depression.  Please call the UHS 
Behavioral Health Clinic at 323-5511 as soon as possible to make an appointment for 
further evaluation or go to the Good Samaritan Emergency Department at 310 S. 
Limestone Street.  We want to help! 
What is Depression? 
Depression is a condition in which you might feel sad, hopeless, or have a decreased 
interest in activities of daily life.  Everyone has times when they feel sad or blue.  However 
if you have been feeling sad or blue for 2 weeks or more, or have had a worsening in 
symptoms it may be depression. 
What are the symptoms of depression? 
 Irritability 
 Difficulty falling asleep, staying asleep, or sleeping too much. 
 Changes in appetite and weight 
 Changes in energy level, usually a decreased energy, but may be periods of feeling 
overexcited 
 Decreased sexual desire 
 Difficulty concentrating or remembering things 
 Feeling hopeless 
 Not caring about anything 
 Unexplained physical symptoms 
 Thoughts about death or suicide 
*Sometimes other conditions may mimic depression; a healthcare provider can help you 
find the cause for your symptoms. 
How is depression diagnosed? 
Your clinician or a mental health therapist can tell you if your symptoms may be related to 
depression.  The University of Kentucky offers several resources that may help you during 
this time. 
 UHS Behavioral Health Clinic may provide you with further evaluation and 
treatment 
o Call 859-323-5511 to make an appointment 
        UK Counseling Center: Consultation and Psychological Services 
o   http://www.uky.edu/StudentAffairs/Counseling/index.html 
o   Eligibility:  Students enrolled and paying for a minimum of 6 credit-
bearing hours in the current semester are eligible for an Initial Assessment 
which may lead to recommendations for services at UKCC and/or other 
providers.  (UKCC services are not extended to residents, post-doctoral 
fellows, or those enrolled solely via the Employee Education Program 
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benefit.)  For summer eligibility, please see the website or call for 
information. 
o   Call 859-257-8701 or go to 201 Frazee Hall to make an appointment M-F 8 
a.m. - 4:30 p.m. or walk in M-F 9 a.m. - 3 p.m. to be seen same-day as 
availability allows. 
 Other local resource in Lexington 
o Comprehensive Care – 1351 Newtown Pike, Lexington, KY 
 Call 859-253-2737 for an appointment 
If you have a healthcare provider at home, they may also be able to offer further evaluation 
and assistance. 
Please do not wait to make an appointment, call one of these resources as a soon as 
possible. 
What can you do? 
 Call UHS or your regular healthcare provider as soon as possible for further 
assistance. 
 If you have thoughts of hurting yourself or others call 911 immediately 
o Please do not wait to talk, someone can help! 
o National Suicide Prevention Lifeline 1-800-273-TALK (8255) 
 Depression may be treated in a variety of ways, your healthcare provider will be 
able to help choose the best treatment for you 
o Medication 
o Therapy 
o Natural and Alternative treatments such as massage, acupuncture, and art 
or music therapies. 
 Maintaining a healthy lifestyle may reduce the symptoms of depression 
o Exercise at least 20 minutes every day 
o Learn which activities make you feel better and do them often 
o Talk to your family and friends  
o Eat a healthy diet 
o Do not drink a lot of caffeine 
o Get 7 to 9 hours of sleep per night 
o Do not abuse alcohol or drugs 
o Learn ways to lower stress, such as breathing exercises or relaxation. 
 
Zieman, G. (2009). Depression: its symptoms and treatment.  Relayhealth. 
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Appendix C. Provider Survey 
This survey pertains to the educational session you attended regarding depression 
screening.  Please answer the following questions to the best of your ability. 
 
1. The educational program provided new information regarding depression 
screening tools 
Strongly Disagree      Strongly Agree 
1  2  3  4  5 
 
2. The educational program provided new information regarding depression 
screening programs at other university health clinics. 
Strongly Disagree      Strongly Agree 
1  2  3  4  5  
 
3. I found the educational program to be beneficial. 
Strongly Disagree      Strongly Agree 
1   2  3  4  5 
 
4.  The educational program increased my awareness of current depression screening 
practices here at UHS 
Strongly Disagree      Strongly Agree 
1  2  3  4  5 
 
5. The information received from the educational program made me think about the 
way I practice. 
Strongly Disagree      Strongly Agree 
1  2  3  4  5 
 
6. The information provided motivated me to screen patients for depression. 
Strongly Disagree      Strongly Agree 
1  2  3  4  5 
 
7. How often did you think you were providing depression screening for patients? 
Never        Every Time 
1  2  3  4  5 
What are 2 factors that are currently impeding depression screening at UHS? 
1. 
 
2. 
Comments: 
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Appendix D. Guideline Summary 
 The guideline, Adult Depression in Primary Care, provides detailed 
recommendations regarding depression screening and implementation in primary care.  
Below is a very brief overview of the recommendations made within this guideline.’ 
1) If depression is suspected, providers use standardized instrument such as the PHQ-9 
to screen for depression.  Providers should be mindful of symptomatic presentation 
of depression, potential co-morbidities, and other potential risk factors. 
2) Diagnosis of major depression should be done through a clinical interview utilizing 
the DSM-4 criteria.  The mnemonic SIGECAPS may help aid the providers’ 
memory of the symptoms of major depression. 
3) If in place, utilize organization’s protocol to assess and minimize suicide risk and 
involve mental health specialist.  If no protocol is in place, it is recommended the 
organization develops one. 
4) Assess for substance misuse, such as alcoholism using the CAGE questionnaire if 
suspected.  Also assess for other psychiatric comorbidities such as bipolar disorder, 
generalized anxiety disorder, or panic disorder. 
5) When evaluating a patient for depression, the provider should also consider medical 
comorbidities, the impact of culture and cultural differences on mental health, and 
special populations such as geriatrics, dementia, and pregnant or postpartum 
women 
6)  The collaborative care approach is recommended for patients with depression.  
This includes a comprehensive treatment plan allowing the patient to share in the 
decision-making process.  The primary goal of treatment (rather psychotherapy, 
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pharmacotherapy, or both) is for the patient to receive remission or be mostly 
symptom free. 
7) The guideline provides a brief table with treatment recommendations based on the 
patient’s PHQ-9 score; see on next page. 
Table 1. Translating Patient Health Questionnaire, 9-Item (PHQ-9) Depression Scores 
into Practice based on DSM-5 Criteria 
PHQ-9 Symptoms 
and Impairment 
PHQ-9 
Severity 
Intensity Treatment Recommendations (for 
treatment durations, see also 
Annotation #10) 
1 to 4 symptoms, 
minimal functional 
impairment 
5-9 Subclinical Education to call if deteriorates  
Physical activity  
Behavioral activation  
If no improvement after one or more 
months, consider referral to behavioral 
health for evaluation  
Consider for persistent depressive 
disorder*  
2 symptoms, #1 or 
#2 >0 score 2+, 
functional 
impairment 
10-14 Mild 
Major 
Depression 
Pharmacotherapy or psychotherapy, or 
both  
Education  
Physical activity  
Behavioral activation  
Initially consider weekly contacts to 
ensure adequate engagement, then at 
least monthly  
≥3 symptoms, #1 or 
#2 >0 score 2 +, 
functional 
impairment 
15-19 Moderate 
Major 
Depression 
Pharmacotherapy, psychotherapy, or 
both  
Education  
Physical activity  
Behavioral activation  
Initially consider weekly contacts to 
ensure adequate engagement, then 
minimum every 2-4 weeks  
≥4 symptoms, 
question #1 or 
#2 >0 score 2 +, 
marked functional 
impairment, motor 
agitation 
≥20 Severe 
Major 
Depression 
Pharmacotherapy necessary and 
psychotherapy when patient is able to 
participate  
Education  
Physical activity  
Behavioral activation  
Weekly contacts until less severe  
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8) Follow-up appointments may be utilized to help the provider assess the patient’s 
response to treatment.  The guideline defines remission as absence of symptoms or 
a PHQ-9 score less than 5; and a response to treatment with a 50% or greater 
reduction in depressive symptoms. 
9) A second table provided within the guideline, assists providers in evidence-based 
decisions regarding continuation and maintenance treatment duration.  As seen 
below. 
Table 2. Depression Medication Treatment Duration Based on Episode 
Episode Treatment Duration* 
1st episode (major depression, single 
episode) 
Acute phase typically lasts 6-12 weeks.  
Continue psychotherapy/medication 
treatment for 4-9 months once remission is 
reached.  
Total = approximately 6-12 months  
2nd episode (major depression, recurrent) Continue medication treatment for 3 years 
once remission is reached. Withdraw 
gradually. 
Persistent depressive disorder or 3+ 
episodes or 2 episodes (major depression, 
recurrent) with complicating factors such 
as:  
Rapid recurrent episodes  
More than 60 years of age at onset of 
major depression  
Severe episodes or family history  
Continue medication treatment indefinitely. 
 
10) With each visit, it is recommended the provider evaluates the dose, duration, type, 
and adherence to treatment.  If unsuccessful the use of a mental health specialist 
may assist in further treatment options such as such as combinations of 
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antidepressants, outpatient versus inpatient treatment, light therapy, or 
electroconvulsive treatment. 
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